What changed in this filing

/stocks — the workspaceLOADING

Item 1. Business

2026-03-09 compared with 2025-03-31 · 21 added, 19 removed, 957 unchanged (4% of the section changed)

15 unchanged sentences

discipline and improving business results.

On January 31, 2025, we consummated our initial

public offering (the “IPO”) of 15,00,000 units.

The units were sold at a price of $10.00 per unit, generating gross proceeds

to the Company of $150,000,000.

Each unit consists of one Class A ordinary share, par value $0.0001 per share, of the Company, and one-half

of one redeemable warrant of the Company, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share

for $11.50 per share.

We granted BTIG, LLC (“BTIG”), the representative of the underwriters, a 45-day option to purchase up

to 2,250,000 additional units solely to cover over-allotments, if any.

On March 17, 2025, the underwriters’ over-allotment option

to purchase up to 2,250,000 additional units expired.

On January 31, 2025, we consummated our initial public offering (the

“IPO”) of 15,000,000 units.

The units were sold at a price of $10.00 per unit, generating gross proceeds to the Company of

$150,000,000.

Each unit consists of one Class A ordinary share, par value $0.0001 per share, of the Company, and one-half of one redeemable

warrant of the Company, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share for $11.50 per share.

We granted BTIG, LLC (“BTIG”), the representative of the underwriters, a 45-day option to purchase up to 2,250,000 additional

units solely to cover over-allotments, if any.

On March 17, 2025, the underwriters’ over-allotment option to purchase up to 2,250,000

additional units expired.

Simultaneously with the closing of the IPO, pursuant to the Private

9 unchanged sentences

of the private units.

On January 29, 2025, in connection with the IPO,

Nicolas Bornozis, Christopher Thomas, and Harry Braunstein were appointed to the board of directors of the Company.

Effective January

29, 2025, each of Nicolas Bornozis, Christopher Thomas, and Harry Braunstein was appointed to the board’s audit committee, compensation

committee and nominating and corporate governance committee.

Christopher Thomas, Nicolas Bornozis and Harry Braunstein are the chairs

of the audit committee, compensation committee and nominating and corporate governance committee, respectively.

On January 29, 2025, in connection with the IPO, Nicolas Bornozis,

Christopher Thomas, and Harry Braunstein were appointed to the board of directors of the Company.

Effective January 29, 2025, each of

Nicolas Bornozis, Christopher Thomas, and Harry Braunstein was appointed to the board’s audit committee, compensation committee

and nominating and corporate governance committee.

Harry Braunstein passed away in November 2025.

In February 2026, the board appointed

Michael Braunstein as a director.

Christopher Thomas, Nicolas Bornozis and Michael Braunstein are the chairs of the audit committee, compensation

committee and nominating and corporate governance committee, respectively.

The Company’s board is comprised of the

2 unchanged sentences

first annual meeting of shareholders after the IPO;

the second class of directors, Class II, consists of Harry Braunstein and Nicolas

the second class of directors, Class II, consists of Michael Braunstein and Nicolas

Bornozis, and will expire at the Company’s second annual meeting of shareholders after the IPO;

925 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 1. Business